Gilgamesh Pharmaceuticals, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie, Gilgamesh To Investigate Potent

Beckley Psytech Limited bolstered its case for psychedelic treatment of depression with Phase IIa data released as the company runs a separate Phase IIb study that it calls the largest US Food and Dr

It is too soon for the Pitchbook and National Venture Capital Association (NVCA) Venture Monitor report detailing fourth quarter 2022 VC investment, including a breakdown of biopharmaceutical fundra